Connection

Jürgen Rehm to Substance-Related Disorders

Back to Details
This is a "connection" page, showing publications Jürgen Rehm has written about Substance-Related Disorders.
Jürgen Rehm
Connection Strength
2.558
Substance-Related Disorders
  1. Use of alcohol, tobacco, cannabis, and other substances during the first wave of the SARS-CoV-2 pandemic in Europe: a survey on 36,000 European substance users. Subst Abuse Treat Prev Policy. 2021 04 26; 16(1):36.
    View in: PubMed
    Score: 0.317
  2. Trends in substance use and in the attributable burden of disease and mortality in the WHO European Region, 2010-16. Eur J Public Health. 2019 08 01; 29(4):723-728.
    View in: PubMed
    Score: 0.281
  3. Commentary on Degenhardt et al. (2019): Harm to others matters in substance use disorders, and so does discordance between the diagnostic systems. Addiction. 2019 03; 114(3):553-554.
    View in: PubMed
    Score: 0.272
  4. Evaluating moderators of beneficial effects of severity-based assignment to substance use treatments in impaired drivers. J Subst Abuse Treat. 2018 10; 93:49-56.
    View in: PubMed
    Score: 0.261
  5. Reducing the health risks derived from exposure to addictive substances. Curr Opin Psychiatry. 2018 07; 31(4):333-341.
    View in: PubMed
    Score: 0.261
  6. Decreases of Life Expectancy Despite Decreases in Non-Communicable Disease Mortality: The Role of Substance Use and Socioeconomic Status. Eur Addict Res. 2018; 24(2):53-59.
    View in: PubMed
    Score: 0.257
  7. Substance use and population life expectancy in the USA: Interactions with health inequalities and implications for policy. Drug Alcohol Rev. 2018 04; 37 Suppl 1:S263-S267.
    View in: PubMed
    Score: 0.256
  8. Substance Use, Health, and Functioning Characteristics of Medical Marijuana Program Participants Compared to the General Adult Population in Ontario (Canada). J Psychoactive Drugs. 2017 Jan-Mar; 49(1):31-38.
    View in: PubMed
    Score: 0.235
  9. Identifying the impacts of the COVID-19 pandemic on service access for people who use drugs (PWUD): A national qualitative study. J Subst Abuse Treat. 2021 10; 129:108374.
    View in: PubMed
    Score: 0.079
  10. "The post-COVID era": challenges in the treatment of substance use disorder (SUD) after the pandemic. BMC Med. 2020 07 31; 18(1):241.
    View in: PubMed
    Score: 0.075
  11. Epidemiology of hallucinogen use in the U.S. results from the National epidemiologic survey on alcohol and related conditions III. Addict Behav. 2019 02; 89:35-43.
    View in: PubMed
    Score: 0.066
  12. Frequent use of emergency departments for mental and substance use disorders. Emerg Med J. 2018 Apr; 35(4):220-225.
    View in: PubMed
    Score: 0.063
  13. The role of mental health and addiction among high-cost patients: a population-based study. J Med Econ. 2018 Apr; 21(4):348-355.
    View in: PubMed
    Score: 0.063
  14. Comparing Medical and Recreational Cannabis Users on Socio-Demographic, Substance and Medication Use, and Health and Disability Characteristics. Eur Addict Res. 2017; 23(3):129-135.
    View in: PubMed
    Score: 0.061
  15. The association between cannabis use and mood disorders: A longitudinal study. J Affect Disord. 2015 Feb 01; 172:211-8.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.